Cargando…
Current treatment of COVID-19 in renal patients: hope or hype?
To date the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), known as COVID-19, is for clinicians the most difficult global therapeutic problem. In this landscape, the management of patients with chronic kidney disease, acute kidney injury or patients undergoing immunosuppressant thera...
Autores principales: | Roberto, Palumbo, Francesco, Londrino, Emanuela, Cordova, Giorgia, Gambardella, Pasquale, Niscola, Sara, Dominijanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520511/ https://www.ncbi.nlm.nih.gov/pubmed/32986137 http://dx.doi.org/10.1007/s11739-020-02510-0 |
Ejemplares similares
-
Correction to: Current treatment of COVID-19 in renal patients: hope or hype?
por: Palumbo, Roberto, et al.
Publicado: (2020) -
Hope and hype
por: De Clercq, Erik
Publicado: (2006) -
Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
por: Núñez-Gil, Iván J., et al.
Publicado: (2020) -
Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?
por: Cosso, Federica, et al.
Publicado: (2023)